Clinical Trial

Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Collect real-world post-market clinical follow-up data on patients treated with the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX)
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2021-05-25; most recent amendment 2026-01-29.
Status change: Recruiting → Active, Not Recruiting 2026-01-29
Status change: Not Yet Recruiting → Recruiting 2021-10-20
Trial Details
NCT Number NCT04907240
Lead Sponsor W.L.Gore & Associates
Conditions Peripheral Artery Disease, Popliteal Aneurysm, Hemodialysis Access, Visceral Artery Aneurysms, Trauma Injury
Enrollment 614 participants
Start Date 2021-10-09
Primary Completion 2026-10 (estimated)
Study Completion 2035-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-02